Clover Biopharmaceuticals, Ltd. (HKG:2197)

Clover Biopharmaceuticals Revenue

In the year 2025, Clover Biopharmaceuticals had annual revenue of 3.51M CNY, down -90.88%. Clover Biopharmaceuticals had revenue of 3.25M in the half year ending June 30, 2025, with 1,166.15% growth.

• Revenue: 3.51M CNY
• Revenue Growth: -90.88%
• P/S Ratio: 945.14
• Revenue / Employee: 14.42K CNY
• Employees: 243
• Market Cap: 3.69B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.51M	-34.91M	-90.88%
Dec 31, 2024	38.42M	-836.00K	-2.13%
Dec 31, 2023	39.26M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-